Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical spironolactone vs clindamycin solution in mild to moderate acne vulgaris
IRCT20120524009844N12Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of spironolactone and clindamycin in acne vulgaris (2 arms), sponsored by Tabriz University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
spironolactoneclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20120524009844N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120524009844N12.